Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intercure Ltd (NQ: INCR )

3.290 -0.090 (-2.66%)
Streaming Delayed Price Updated: 2:09 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Intercure Ltd

< Previous 1 2 3 Next >
InterCure Teams Up Wit Praetorian Global To License, Manufacture And Distribute Cannabis Brand 'Binske'
InterCure Ltd. 
Via Benzinga
Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) and Canndoc Ltd., a subsidiary of InterCure Ltd. 
Via Benzinga
Israeli Cannabis Producer Touts Record Q3 Revenue, Gross Profit Increase
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, announced on Tuesday its financial and operating results for the third quarter ended September 30, 2022. 
Via Benzinga
InterCure Hits Record Preliminary Q3 Revenue Of $29M
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) released preliminary financial results for the third quarter of 2022, revealing record revenue estimated to be CA$39 million, 63% over the... 
Via Benzinga
InterCure Q2 2022 Revenue Grows 119%, What About Profit?
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) released its financial results for the second quarter of 2022, revealing record revenue of approximately CA$37 million, more than double the... 
Via Benzinga
Clever Leaves 2Q: Neutraceuticals Up, Preparing For Cannabis Flower Exports From Colombia
The Analyst 
Via Benzinga
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth
InterCure Ltd. 
Via Benzinga
Israel's Marijuana Bubble Bursts: Tel Aviv Stock Exchange Eliminates TA-Cannabis Index, Ending Three-Year High
It was just three years ago that a broad swath of Israeli society, including former prime ministers, defense bigwigs and celebrities seemed to be enamored by the country's up-and-coming cannabis... 
Via Benzinga
InterCure Reports Record Preliminary Q2 2022 Revenue – More Than Double YoY
InterCure Ltd. 
Via Benzinga
Clever Leaves To Ship First Export Of Cannabis To Israeli Partner InterCure
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) will ship the first commercial export to Israel of high THC flower for medical use from its facility in Portugal through its partnership with... 
Via Benzinga
Cannabis Stocks Struggle Through Q2 2022
An overview of how cannabis stocks fared in Q2 and what investors should understand about the space. 
Via Talk Markets
Invest In The Future Of Medicine Says Berner, CEO Of Cookies At Benzinga's Psychedelics Capital Conference
Berner, the famed rapper, co-founder and CEO of the highly successful cannabis and clothing brand, Cookies, was one of the main speakers at Benzinga's Psychedelics Capital Conference last April at the... 
Via Benzinga
Cannabis Dispensary Roundup: Cookies' CBD Products Now Available In Austria, Parallel & Texas Original Each Open New Stores
Parallel To Open Another Surterra Wellness Store In Florida Parallel is opening a second Surterra Wellness medical marijuana dispensary in Orlando. 
Via Benzinga
InterCure And Berner's Cookies Launch Flagship Retail Location In Vienna, Austria
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) opened the first flagship Cookies store in Austria, located in the Neubau district of Vienna. 
Via Benzinga
InterCure And Berner's Cookies Launch Flagship Cannabis Pharmacy In Be'er Sheva, Israel
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) is opening its flagship Cookies pharmacy in Be'er Sheva, the largest city in Israel's southern region, known as the capital of the Negev. 
Via Benzinga
InterCure Begins 2022 With Record-Breaking Q1 Financial Results, Up 9% Sequentially From Prior Quarter
InterCure (NASDAQ: INCR) released its financial results for the first quarter of 2022 and provided shareholders with a business update. All amounts are expressed in Canadian dollars or New Israeli... 
Via Benzinga
InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, has announced its estimated financial and operating results for the fourth quarter and year ended December... 
Via Benzinga
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results
Clever Leaves Holdings Inc. (NASDAQ:CLVRW), a leading mul... 
Via Benzinga
InterCure And Clever Leaves Enter Into International Strategic Partnership
InterCure Ltd. (NASDAQ:INCR) (TSX: 
Via Benzinga
Berner: Rapper, Entrepreneur, Social Justice Advocate To Participate In Benzinga Psychedelics Capital Conference
Berner, the Bay Area rapper, 
Via Benzinga
Israel Set To Decriminalize Rec Cannabis As More Marijuana Businesses Join The Emerging Market
It seems that Israel is taking steps toward the legalization of recreational cannabis, with the governmen... 
Via Benzinga
Israel Moves To Normalize CBD, Two-Year Path To Market Expected
Israel recently took steps toward normalizing CBD and related cannabinoids, declaring the hemp compound is not a drug, though... 
Via Benzinga
InterCure Teams Up With Altman Health To Bring CBD To Israel Including Charlotte's Web Branded Products
InterCure Ltd. (NASDAQ:INCR) (TSX: 
Via Benzinga
InterCure To Acquire Israel-Based Medical Cannabis Producer Better For $35M
InterCure Ltd. (NASDAQ:INCR) (TSX: 
Via Benzinga
52 Biggest Movers From Yesterday
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences... 
Via Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60... 
Via Benzinga
25 Stocks Moving in Monday's Pre-Market Session
Gainers Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 52.8% to $0.65 in pre-market trading after declining 6% on Friday. TC BioPharm (Holdings) plc (NASDAQ: TCBP)... 
Via Benzinga
The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More
Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents 
Via Benzinga
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
Guernsey Issues Its First-Ever Medical Marijuana License: What It Means For This British Crown Territory
The Bailiwick of Guernsey Cannabis Agency has issued its first license in relation to CBD production. A bailiwick, by the way, is the area of jurisdiction of a... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.